Here we provide the updated version of the guidelines of the European Association for
Palliative Care (EAPC) on the use of opioids for the treatment of cancer pain. The update …

Background: Pain is a major health care problem for patients with cancer: despite the
existence of guidelines for cancer pain management, undertreatment is a widespread …

According to a systematic review of the literature, pain prevalence ranges from 33% in
patients after curative treatment to 59% in patients on anticancer treatment and to 64% in …

The experience of pain in cancer is widely accepted as a major threat to quality of life, and
the relief of pain has emerged as a priority in oncology care. Pain is associated with both the …

It is estimated that nearly a third of people who abuse drugs started with prescription opioid
medicines. Approximately, 11.5 million Americans used prescription drugs recreationally in …

A task group of the Science Committee of the Association for Palliative Medicine of Great
Britain and Ireland (APM) was convened to produce some up-to-date, evidence-based …

Inadequate cancer pain relief has been documented extensively across historical records. In
response, in 1986, the World Health Organization (WHO) developed guidelines for cancer …

Opioids have proven very useful for treatment of acute pain and cancer pain, and in the
developed countries opioids are increasingly used for treatment of chronic non-malignant …

Cancer pain significantly affects the diagnosis, quality of life and survival of patients with
cancer. During the past decade, preclinical and clinical data has begun to provide insight …

Malignant bowel obstruction (MBO) is a frequent complication in advanced cancer patients,
especially in those with abdominal tumors. Clinical management of MBO requires a specific …